Sökresultat - Aaron N. Hata
- Visas 1 - 20 av 60 resultat
- Gå till nästa sida
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies av Clemens Grassberger, David M. McClatchy, Changran Geng, Sophia C. Kamran, Florian J. Fintelmann, Yosef E. Maruvka, Zofia Piotrowska, Henning Willers, Lecia V. Sequist, Aaron N. Hata, Harald Paganetti
Publicerad 2019Artigo -
8
Unprocessed genomic uracil as a source of DNA replication stress in cancer cells av Sneha Saxena, Christopher S. Nabel, Turner W. Seay, Parasvi S. Patel, Ajinkya S. Kawale, Caroline R. Crosby, Helene Tigro, Eugene Oh, Matthew G. Vander Heiden, Aaron N. Hata, Zucai Suo, Lee Zou
Publicerad 2024Artigo -
9
Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases av Hironori Uruga, Emine Bozkurtlar, Tiffany G. Huynh, Alona Muzikansky, Yasushi Goto, María Gomez‐Caraballo, Aaron N. Hata, Justin F. Gainor, Eugene J. Mark, Jeffrey A. Engelman, Michael Lanuti, Mari Mino‐Kenudson
Publicerad 2016Artigo -
10
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction av Kyle Vaccaro, Juliet Allen, Troy W. Whitfield, Asaf Maoz, Sarah Reeves, José Velarde, Dian Yang, Anna Meglan, Juliano Ribeiro, Jasmine Blandin, Nicole Phan, George W. Bell, Aaron N. Hata, Kipp Weiskopf
Publicerad 2024Artigo -
11
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity av Lynnette Marcar, Kankana Bardhan, Liliana Gheorghiu, Patrick Dinkelborg, Heike N. Pfäffle, Qi Liu, Meng Wang, Zofia Piotrowska, Lecia V. Sequist, Kerstin Borgmann, Jeffrey Settleman, Jeffrey A. Engelman, Aaron N. Hata, Henning Willers
Publicerad 2019Artigo -
12
Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers av Aaron N. Hata, Alan T. Yeo, Anthony C. Faber, Eugene Lifshits, Zhao Chen, Katherine A. Cheng, Zandra E. Walton, Kristopher A. Sarosiek, Anthony Letai, Rebecca S. Heist, Mari Mino‐Kenudson, Kwok‐Kin Wong, Jeffrey A. Engelman
Publicerad 2014Artigo -
13
Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment av Tiffany G. Huynh, Vicente Morales‐Oyarvide, Meghan Campo, Justin F. Gainor, Emine Bozkurtlar, Hironori Uruga, Ling Zhao, María Gomez‐Caraballo, Aaron N. Hata, Eugene J. Mark, Michael Lanuti, Jeffrey A. Engelman, Mari Mino‐Kenudson
Publicerad 2016Artigo -
14
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation Diversity av Ibiayi Dagogo‐Jack, Marguerite Rooney, W. Marston Linehan, Rebecca J. Nagy, Beow Y. Yeap, Harper Hubbeling, Emily Chin, Jennifer Ackil, Anna F. Farago, Aaron N. Hata, Jochen K. Lennerz, Justin F. Gainor, Richard B. Lanman, Alice T. Shaw
Publicerad 2019Artigo -
15
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC av Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Ayako Nakashoji, Hideko Isozaki, Mototsugu Shimokawa, Chie Kikutake, Mikita Suyama, Asato Hashinokuchi, Kazuki Takada, Tomoyoshi Takenaka, Tomoharu Yoshizumi, Tetsuya Mitsudomi, Aaron N. Hata, Donald Küfe
Publicerad 2023Artigo -
16
A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor av Ibiayi Dagogo‐Jack, Philicia Moonsamy, Justin F. Gainor, Jochen K. Lennerz, Zofia Piotrowska, W. Marston Linehan, Inga T. Lennes, Lecia V. Sequist, Alice T. Shaw, Kelly Goodwin, Sara E. Stevens, Andrew Do, Subba R. Digumarthy, Kristin S. Price, Alona Muzikansky, Aaron N. Hata, Rebecca S. Heist
Publicerad 2021Artigo -
17
TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant Melanoma av Ryan B. Corcoran, S. Michael Rothenberg, Aaron N. Hata, Anthony C. Faber, Adriano Piris, Rosalynn M. Nazarian, Ronald D. Brown, Jason T. Godfrey, Daniel Winokur, John R. Walsh, Mari Mino‐Kenudson, Shyamala Maheswaran, Jeffrey Settleman, Jennifer A. Wargo, Keith T. Flaherty, Daniel A. Haber, Jeffrey A. Engelman
Publicerad 2013Artigo -
18
Targeting TREX1 induces innate immune response in drug-resistant Small Cell Lung Cancer av Takahiko Murayama, Navin R. Mahadevan, Catherine B. Meador, Elena Ivanova, Yuqiao Pan, Erik H. Knelson, Tetsuo Tani, Jun Nakayama, Xueying Ma, Tran C. Thai, Yin P. Hung, William Kim, Hideo Watanabe, Kathy Q. Cai, Aaron N. Hata, Cloud P. Paweletz, David A. Barbie, Israel Cañadas
Publicerad 2024Artigo -
19
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells av Moiez Ali, Min Lu, Hazel X. Ang, Ryan S. Soderquist, Christine E. Eyler, Haley M. Hutchinson, Carolyn Glass, Christopher F. Bassil, Omar Lopez, D. Lucas Kerr, Christina J. Falcon, Helena A. Yu, Aaron N. Hata, Collin M. Blakely, Caroline E. McCoach, Trever G. Bivona, Kris C. Wood
Publicerad 2022Artigo -
20
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer av Justin F. Gainor, Diane Tseng, Satoshi Yoda, Ibiayi Dagogo‐Jack, Luc Friboulet, W. Marston Linehan, Harper Hubbeling, Leila Dardaei, Anna F. Farago, Katherine R. Schultz, Lorin A. Ferris, Zofia Piotrowska, James C.H. Hardwick, Donghui Huang, Mari Mino‐Kenudson, A. John Iafrate, Aaron N. Hata, Beow Y. Yeap, Alice T. Shaw
Publicerad 2017Artigo
Sökverktyg:
Relaterade ämnen
Cancer research
Biology
Medicine
Cancer
Internal medicine
Genetics
Gene
Lung cancer
Oncology
Biochemistry
Mutant
Cell biology
KRAS
Pathology
Colorectal cancer
Malignant pleural effusion
Apoptosis
Crizotinib
Immunology
Mutation
Receptor
Adenocarcinoma
Epidermal growth factor receptor
Pharmacology
Targeted therapy
Anaplastic lymphoma kinase
Chemistry
Gene expression
Signal transduction
ALK inhibitor